This information has been disclosed pursuant to Rule 26 of the AIM Rules for Companies and was last updated on 14th November 2022.
Country of incorporation and main country of operation
Kromek Group plc is incorporated in England (Registration Number 8661469). Its main country of operation is the United Kingdom.
Details of exchanges and trading platforms
Kromek securities (EPIC code: KMK) are not listed or traded on any exchanges or trading platforms other than AIM.
Number of securities in issue, percentage of securities not in public hands and significant shareholders.
See Securities in Issue and Significant Shareholders
Description of the business
Kromek is a UK-based platform technology company and a leading developer of high-performance radiation technology products based on cadmium zinc telluride (CZT) and other advanced technologies. Our products enable direct materials identification in three high-value global markets: medical imaging, nuclear detection, and security screening.
More recently, the Group has developed technology and products in a new market segment, biosecurity, for the detection and identification of airborne pathogens (bacteria and viruses) including the detection of COVID-19.
With manufacturing facilities in the UK and US, Kromek sells internationally to 50 countries through partnerships and distribution channels in Asia, Europe, and North America, to a global customer base ranging from national governments and regulatory bodies to international airports and research institutes, and from major energy providers to the world’s largest technology and medical equipment groups. Our facility in Pennsylvania was purpose built and designed to be a world-class manufacturing base to produce medical imaging products.
Details of the nominated adviser and other key advisers
Directors and biographical details
Directors’ committee memberships
Details of the corporate governance code that the AIM company has decided to apply together with details of compliance with that code
Latest Annual Report, all other financial reports published in the past 12 months, and annual accounts for the last three years
All notifications the company has made in the past 12 months
Admission Document
Any circulars / shareholder publications sent to shareholders in the past 12 months
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of Kromek Group’s shares
